Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Quantumscape Corp (QS) vs Verisign, Inc. (VRSN) Price & Performance

Quantumscape CorpTrade
Verisign, Inc.Trade

Price performance (Past 24H)

Key statistics

Quantumscape Corp vs Verisign, Inc. — how do they compare? Quantumscape Corp trades at $4.56 (market cap $2.82B), while Verisign, Inc. trades at $305.38 (market cap $26.92B). The key difference: Verisign, Inc. is far larger — about 9.5× Quantumscape Corp's market cap, and Verisign, Inc. pays a 1.09% dividend while Quantumscape Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quantumscape Corp for 37 Days and Verisign, Inc. for 123 Days on average.

QSVRSN
Market Cap
$2.82B$26.92B
Volume
21,878,2461,921,402
Sector
Consumer CyclicalTechnology
52-Week High
$18.44$310.00
52-Week Low
$4.52$211.49
Typical Hold Time
37 Days123 Days
Enterprise Value
$2.03B$28.23B
Dividend Yield
—1.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Quantumscape Corp

QuantumScape (QS) trades at $4.52, down 2.8% on the day, reflecting ongoing investor skepticism about the solid-state battery developer's path to commercialization. The stock shows bearish technical signals with negative moving averages and oscillators, while fundamental challenges persist with zero revenue, negative EBITDA of -$358.25M (2025), and consecutive quarterly losses. Recent news highlights commercialization delays and insider selling, though the company continues ramping pilot production lines for automotive and new market applications.

The outlook remains high-risk with commercialization not expected until 2029, creating significant execution and competitive threats. While the consensus price target of $10.35 suggests potential upside from current levels, analyst sentiment is cautious with 73% hold ratings. Investment opportunity exists only for speculative investors comfortable with pre-revenue developmental stage risks and extended timelines to profitability.

Verisign, Inc.

VeriSign (VRSN) trades at $301.59, up 2.5% today, with a bullish technical signal and strong institutional buying. The company reported robust Q2 2026 earnings with revenue up 6% year-over-year and EPS of $2.38, though it missed expectations. High profitability is evident with a net income margin near 50%, and cash flow trends are improving. Recent news includes a class-action antitrust lawsuit and insider selling by the CEO, but analyst consensus remains positive.

The outlook is supported by solid fundamentals and a consensus price target of $348, offering ~15% upside. Key risks include legal challenges from the antitrust suit and reliance on domain registration growth. Earnings momentum and institutional accumulation provide tailwinds, but investors should weigh litigation risks against the company's stable cash flows and market position.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QS
89% Buy11% Sell
Avg holding period · 37 Days
VRSN
89% Buy11% Sell
Avg holding period · 123 Days

Top news

Latest headlines on both assets

About Quantumscape Corp

QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.

Read more on QS →

About Verisign, Inc.

Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.

Read more on VRSN →